ElMosbah D, Khattab M, Emam S, Miniawy H
Inflammopharmacology. 2022; 30(6):2537-2546.
PMID: 35930173
PMC: 9700632.
DOI: 10.1007/s10787-022-01042-7.
Abe S, Yunoki T, Hayashi A
Am J Ophthalmol Case Rep. 2022; 27:101630.
PMID: 35845748
PMC: 9284442.
DOI: 10.1016/j.ajoc.2022.101630.
Patwardhan A, Spencer C
Pediatr Rheumatol Online J. 2019; 17(1):56.
PMID: 31429786
PMC: 6702719.
DOI: 10.1186/s12969-019-0361-2.
Aggarwal R, Oddis C
Degener Neurol Neuromuscul Dis. 2019; 2:43-52.
PMID: 30890877
PMC: 6065613.
DOI: 10.2147/DNND.S19899.
Needham M, Mastaglia F
Neurotherapeutics. 2015; 13(1):132-46.
PMID: 26586486
PMC: 4720681.
DOI: 10.1007/s13311-015-0394-2.
"Orbiting around" the orbital myositis: clinical features, differential diagnosis and therapy.
Montagnese F, Wenninger S, Schoser B
J Neurol. 2015; 263(4):631-40.
PMID: 26477021
DOI: 10.1007/s00415-015-7926-x.
Cost-utility analysis of intravenous immunoglobulin for the treatment of steroid-refractory dermatomyositis in Thailand.
Bamrungsawad N, Chaiyakunapruk N, Upakdee N, Pratoomsoot C, Sruamsiri R, Dilokthornsakul P
Pharmacoeconomics. 2015; 33(5):521-31.
PMID: 25774016
DOI: 10.1007/s40273-015-0269-8.
Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.
Moran E, Mastaglia F
Clin Exp Immunol. 2014; 178(3):405-15.
PMID: 25171057
PMC: 4238868.
DOI: 10.1111/cei.12445.
The treatment strategies of autoimmune disease may need a different approach from conventional protocol: a review.
Chandrashekara S
Indian J Pharmacol. 2012; 44(6):665-71.
PMID: 23248391
PMC: 3523489.
DOI: 10.4103/0253-7613.103235.
Ocular myositis.
Fraser C, Skalicky S, Gurbaxani A, McCluskey P
Curr Allergy Asthma Rep. 2012; 13(3):315-21.
PMID: 23093472
DOI: 10.1007/s11882-012-0319-7.
Advances in the diagnosis, pathogenesis and treatment of CIDP.
Dalakas M
Nat Rev Neurol. 2011; 7(9):507-17.
PMID: 21844897
DOI: 10.1038/nrneurol.2011.121.
Immunotherapy of inflammatory myopathies: practical approach and future prospects.
Dalakas M
Curr Treat Options Neurol. 2011; 13(3):311-23.
PMID: 21365201
DOI: 10.1007/s11940-011-0119-8.
Therapeutic advances and future prospects in immune-mediated inflammatory myopathies.
Dalakas M
Ther Adv Neurol Disord. 2010; 1(3):157-66.
PMID: 21180574
PMC: 3002554.
DOI: 10.1177/1756285608097463.
Immunotherapy of myositis: issues, concerns and future prospects.
Dalakas M
Nat Rev Rheumatol. 2010; 6(3):129-37.
PMID: 20125096
DOI: 10.1038/nrrheum.2010.2.
Ocular myositis: diagnostic assessment, differential diagnoses, and therapy of a rare muscle disease - five new cases and review.
Schoser B
Clin Ophthalmol. 2009; 1(1):37-42.
PMID: 19668464
PMC: 2699981.
How citation distortions create unfounded authority: analysis of a citation network.
Greenberg S
BMJ. 2009; 339:b2680.
PMID: 19622839
PMC: 2714656.
DOI: 10.1136/bmj.b2680.
[Current treatments of dermatomyositis and polymyositis].
Richter J, Iking-Konert C
Z Rheumatol. 2007; 66(8):686-92.
PMID: 17999071
DOI: 10.1007/s00393-007-0226-9.
Advances in the immunobiology and treatment of inflammatory myopathies.
Dalakas M
Curr Rheumatol Rep. 2007; 9(4):291-7.
PMID: 17688838
DOI: 10.1007/s11926-007-0047-5.
